NHS England to offer 'potentially life-saving' drug for aggressive breast cancer, Breast cancer

Women with triple negative breast cancer will gain access to pembrolizumab after deal with its manufacturer

New NHS drug offers lifeline to 1,600 women with rare aggressive breast cancer

How the Covid-19 pandemic affected cancer screening services and what impact it has had on

NICE says new triple negative advanced breast cancer drug too expensive for NHS use, News, News

Breast cancer survival could be extended with two new drug combinations

Treatment for triple-negative breast cancer will now be available for patients in England

ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer - The Institute of Cancer Research, London

Breast cancer: NHS England offers life-saving drug that can make tumour 'disappear

The rise of the 'long-waiter' – why cancer waiting times are showing the pressure more than ever before - Cancer Research UK - Cancer News

Kadcyla: Breast cancer drug breakthrough will see thousands women live longer and suffer no hair loss - Mirror Online

Action Cancer ambassador shares her journey after routine screening diagnosis

NHS England to roll out 'potentially life-saving' breast cancer drug

Life-saving' breast cancer drug to be offered on NHS